Hologic finalized its acquisition of the U.S. business assets of Trex Medical (SCAN 8/30/00) earlier this month and will use these assets to reposition itself as a full-line, digital-focused x-ray supplier, according to S. David Ellenbogen,
Hologic finalized its acquisition of the U.S. business assets of Trex Medical (SCAN 8/30/00) earlier this month and will use these assets to reposition itself as a full-line, digital-focused x-ray supplier, according to S. David Ellenbogen, chairman and CEO of the Bedford, MA, bone densitometry vendor.
The amorphous selenium flat-panel digital detector technology of Hologics Direct Radiography (DRC) subsidiary, acquired a year ago, will be applied to both of Trexs product lines, mammographic and radiographic, Ellenbogen said.
The acquisition of Trex is really a scheme of vertical integration, Ellenbogen told SCAN. The centerpiece for the strategy will continue to be the plates, which we will use for both radiographic and mammographic purposes.
Hologic will keep production of the Trex radiographic line, combining manufacture of products formerly sold by Continental X-ray, Bennett X-ray, and XRE, in its Littleton, MA, facility but will market this equipment under the Hologic label. The Lorad label will be continued for the mammographic products produced in Danbury, CT.
As one of his first moves to reposition the former Trex business, Ellenbogen hired Jack Cumming as Lorad president. Cumming is a veteran medical imaging industry analyst who runs his own company, HealthCare Markets Group, out of Hilton Head, SC.
Hologic plans to take over the Trex booth at the upcoming RSNA meeting, Ellenbogen said. The firm will show initial work on converting the former Trex digital mammography technology over to the DRC flat-panel detector, although this work-in-progress system will also be on display with its original CCD-based detectors.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.